Literature DB >> 12664633

12(S)-HETE, pleiotropic functions, multiple signaling pathways.

Charles K Szekeres1, Mohit Trikha, Kenneth V Honn.   

Abstract

The arachidonic acid metabolite of 12 lipoxygenase, 12(S)-hydroxyeicosatetraenoic acid (12(S)-HETE) promotes metastatic behavior of tumor cells (1). In this study we set out to identify 12(S)-HETE stimulated signaling pathways, and their contribution to cellular functions in A431 epidermoid carcinoma. 1) 12(S)-HETE signaling involves extracellular-regulated protein kinase (ERK1/2), protein kinase C (PKC), phosphatidylinositol 3-kinase (PI3 kinase) and Src kinase. 2) 12(S)-HETE stimulates cell migration on laminin, which is eliminated by PKC and PI3 kinase inhibitors, reduced by 50% with Src inhibitor, but unaffected by inhibition of ERK1/2. 3) 12(S)-HETE stimulated spreading on fibronectin relies on ERK1/2 and PI3 kinase activities, but not on PKC or Src. 4) Focal adhesion kinase, a key organizer of focal adhesions, is tyrosine phosphorylated in response of 12(S)-HETE treatment, which requires Src, but not PKC, PI3 kinase or ERK1/2 activity. 5) Inhibition of 12 lipoxygenase leads to apoptosis in serum starved A431 cells. 12(S)-HETE stimulated p90Rsk and Akt, key players in an ERK and a PI3 kinase (respectively) dependent anti apoptotic pathways.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12664633     DOI: 10.1007/978-1-4615-0193-0_78

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  8 in total

Review 1.  Basic aspects of tumor cell fatty acid-regulated signaling and transcription factors.

Authors:  Andrea Comba; Yi-Hui Lin; Aldo Renato Eynard; Mirta Ana Valentich; Martín Ernesto Fernandez-Zapico; Marìa Eugenia Pasqualini
Journal:  Cancer Metastasis Rev       Date:  2011-12       Impact factor: 9.264

2.  Pulse inhibition of histone deacetylases induces complete resistance to oxidative death in cortical neurons without toxicity and reveals a role for cytoplasmic p21(waf1/cip1) in cell cycle-independent neuroprotection.

Authors:  Brett Langley; Melissa A D'Annibale; Kyungsun Suh; Issam Ayoub; Aaron Tolhurst; Birgül Bastan; Lichuan Yang; Brian Ko; Marc Fisher; Sunghee Cho; M Flint Beal; Rajiv R Ratan
Journal:  J Neurosci       Date:  2008-01-02       Impact factor: 6.167

3.  Role of Src tyrosine kinase in the atherogenic effects of the 12/15-lipoxygenase pathway in vascular smooth muscle cells.

Authors:  Marpadga A Reddy; Saurabh Sahar; Louisa M Villeneuve; Linda Lanting; Rama Natarajan
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-12-18       Impact factor: 8.311

4.  Dynamic adhesions and MARCKS in melanoma cells.

Authors:  Adriana Estrada-Bernal; Jesse C Gatlin; Somkiat Sunpaweravong; Karl H Pfenninger
Journal:  J Cell Sci       Date:  2009-06-09       Impact factor: 5.285

Review 5.  Emerging targets in lipid-based therapy.

Authors:  Stephanie C Tucker; Kenneth V Honn
Journal:  Biochem Pharmacol       Date:  2012-12-20       Impact factor: 5.858

Review 6.  12- and 15-lipoxygenases in adipose tissue inflammation.

Authors:  Banumathi K Cole; David C Lieb; Anca D Dobrian; Jerry L Nadler
Journal:  Prostaglandins Other Lipid Mediat       Date:  2012-08-20       Impact factor: 3.072

7.  Up-regulation of 12(S)-lipoxygenase induces a migratory phenotype in colorectal cancer cells.

Authors:  T Klampfl; E Bogner; W Bednar; L Mager; D Massudom; I Kalny; C Heinzle; W Berger; S Stättner; J Karner; M Klimpfinger; G Fürstenberger; P Krieg; B Marian
Journal:  Exp Cell Res       Date:  2011-12-29       Impact factor: 3.905

8.  Inhibition of transforming growth factor-β-activated kinase-1 blocks cancer cell adhesion, invasion, and metastasis.

Authors:  D M Ray; P H Myers; J T Painter; M J Hoenerhoff; K Olden; J D Roberts
Journal:  Br J Cancer       Date:  2012-05-29       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.